Amerigen Life Sciences Llp - Company Profile

It is a pharma limited liability partnership based in Ahmedabad, Gujarat, India, established in 2018.
2018 Ahmedabad, Gujarat, India Active
Last Updated:
Access Report
About Amerigen Life Sciences Llp

Amerigen Life Sciences Llp, a active limited liability partnership, was established on 09 March 2018 in Ahmedabad, Gujarat, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds LLPIN: AAM-2013. Registered under ROC Roc Ahmedabad. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Nirav Nalinkumar Vyas (Designated Partner), Jalpaben Niravkumar Vyas (Designated Partner). Past directors included Sanchit Kaushik Chaturvedi, Payal Vinodkumar Patel, Dhaval Atulbhai Vyas. Its latest date of accounts and solvency statement 31 March 2024. It is based at B1-13, Galaxy Signature,Science City Road, Opp. Sukun Bunglow, Sola,, Ahmedabad, Gujarat, 380060.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAM-2013

  • Incorporation Date

    09 March 2018

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Ahmedabad

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 7 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
Company report

Amerigen Life Sciences Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Amerigen Life Sciences Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Amerigen Life Sciences Llp?
Current Designated Partners
Name Designation Appointment Date Status
Nirav Nalinkumar Vyas Designated Partner 02 Jan 2021 Current
Jalpaben Niravkumar Vyas Designated Partner 09 Mar 2018 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Designated Partner 31 Mar 2022 Past
Pramod Abcsdd Designated Partner 17 Sep 2019 Past
Pramod Abcsdd Designated Partner 02 Jan 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Amerigen Life Sciences Llp.

Enhance accessibility to Amerigen Life Sciences Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Amerigen Life Sciences Llp revenue growth over time
Amerigen Life Sciences Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Amerigen Life Sciences Llp?

Unlock access to Amerigen Life Sciences Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Amerigen Life Sciences Llp?

Unlock and access historical data on people associated with Amerigen Life Sciences Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Amerigen Life Sciences Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amerigen Life Sciences Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Amerigen Life Sciences Llp
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Amerigen Life Sciences Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was documented.

  • Statement of Assets & Liabilities

    Amerigen Life Sciences Llp has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was recorded as a recent event.

  • Director Appointment

    The activity Nirav Nalinkumar Vyas was appointed as a Designated Partner was appointed as a Designated Partner on 02 Jan 2021 & has been associated with this company since 5 years 2 months . was completed.

  • Director Appointment

    Jalpaben Niravkumar Vyas was appointed as a Designated Partner was appointed as a Designated Partner on 09 Mar 2018 & has been associated with this company since 7 years 11 months . was recorded as a recent event.

  • LLP Incorporation

    The activity Amerigen Life Sciences Llp was registered on 09 Mar 2018 with Roc Ahmedabad & aged 7 years 11 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Amerigen Life Sciences Llp?

The LLPIN of Amerigen Life Sciences Llp is AAM-2013.

Where is Amerigen Life Sciences Llp headquartered?

Amerigen Life Sciences Llp is headquartered at B1-13, Galaxy Signature,Science City Road, Opp. Sukun Bunglow, Sola,, Ahmedabad, Gujarat, 380060.

When was Amerigen Life Sciences Llp incorporated?

Amerigen Life Sciences Llp was incorporated on 09 March 2018.

Who are the current directors of Amerigen Life Sciences Llp?

The current directors of Amerigen Life Sciences Llp are

What is the primary industry of Amerigen Life Sciences Llp?

The primary industry of Amerigen Life Sciences Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available